Advanced Biomed Inc Depreciation
Advanced Biomed Inc (ADVB) reported Depreciation of $9.33 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-05-15
- Advanced Biomed Inc depreciation for the quarter ending 2026-03-31 was $9.33K, a 58.56% decline year-over-year.
- Advanced Biomed Inc depreciation for the quarter ending 2025-12-31 was $14.46K, a 34.21% decline year-over-year.
- Advanced Biomed Inc depreciation for the quarter ending 2025-09-30 was $47.99K, a 28.68% decline year-over-year.
- Advanced Biomed Inc depreciation for the quarter ending 2025-06-30 was $156.87K, a 30.20% increase year-over-year.
- Advanced Biomed Inc depreciation for fiscal 2025 was $224.83K, a 16.19% decline from fiscal 2024.
- Advanced Biomed Inc depreciation for fiscal 2024 was $268.28K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $9.33K 10-Q · filed 2026-05-15 | $23.79K derived: sum of 2 quarters · filed 2026-05-15 | $44.46K 10-Q · filed 2026-05-15 | $228.65K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $14.46K 10-Q · filed 2026-02-13 | $35.13K 10-Q · filed 2026-02-13 | $219.32K derived: sum of 3 quarters · filed 2026-02-13 | $241.83K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-09-30 | $47.99K 10-Q · filed 2025-11-19 | $204.86K derived: sum of 2 quarters · filed 2025-11-19 | $227.37K derived: sum of 3 quarters · filed 2026-05-15 | $249.35K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $156.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $179.37K derived: sum of 2 quarters · filed 2026-05-15 | $201.36K derived: sum of 3 quarters · filed 2026-05-15 | $224.83K 10-K · filed 2025-10-08 | |||
| 2025-03-31 | $22.51K 10-Q · filed 2026-05-15 | $47.95K 10-Q · filed 2025-05-15 | $44.49K derived: sum of 2 quarters · filed 2026-05-15 | $67.97K 10-Q · filed 2026-05-15 | $180.75K 10-Q · filed 2025-05-15 | $232.26K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $21.98K 10-Q · filed 2026-02-13 | $65.52K 10-Q · filed 2025-04-15 | $45.46K 10-Q · filed 2026-02-13 | $132.81K 10-Q · filed 2025-04-15 | $209.75K derived: sum of 3 quarters · filed 2026-02-13 | $260.86K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $67.29K 10-Q · filed 2025-11-19 | $187.77K derived: sum of 2 quarters · filed 2025-11-19 | $238.88K derived: sum of 3 quarters · filed 2025-11-19 | $296.78K derived: sum of 4 quarters · filed 2025-11-19 | |||
| 2024-06-30 | $120.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-08 | $171.59K derived: sum of 2 quarters · filed 2025-10-08 | $229.49K derived: sum of 3 quarters · filed 2025-10-08 | $268.28K 10-K · filed 2025-10-08 | |||
| 2024-03-31 | $51.11K 10-Q · filed 2025-05-15 | $109.01K derived: sum of 2 quarters · filed 2025-05-15 | $147.80K 10-Q · filed 2025-05-15 | ||||
| 2023-12-31 | $57.90K 10-Q · filed 2025-04-15 | $96.69K 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |